Sujal Shah

Companies

• Tvardi Therapeutics, Inc.Board member Apr 17, 2025 to now¹
• CymaBay Therapeutics (United States)Board member Jul 24, 2017 to Mar 22, 2024²
• CymaBay Therapeutics (United States)Chief executive officer May 1, 2017 to Mar 22, 2024³
• CymaBay Therapeutics (United States)President Jul 24, 2017 to May 19, 2020²
• CymaBay Therapeutics (United States)Chief financial officer Oct 11, 2013 to Jan 23, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCymaBay Therapeutics (United States)0 shares⁵Mar 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 22, 2024Returned to company 96,250 shares of CymaBay Therapeutics (United States)⁵
• Mar 22, 2024Returned to company 310,420 shares of CymaBay Therapeutics (United States)⁵
• Mar 13, 2024Exercised options 1 shares at $2.94 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 2,288 shares at $5.78 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 22,076 shares at $4.05 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 14,372 shares at $8.43 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 3,125 shares at $11.69 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 18,899 shares at $9.21 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 52,084 shares at $1.72 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 14,625 shares at $1.06 of CymaBay Therapeutics (United States)⁶
• Mar 13, 2024Exercised options 11,649 shares at $10.00 of CymaBay Therapeutics (United States)⁶
• Jan 24, 2024Granted 96,250 shares of CymaBay Therapeutics (United States)⁷
• Dec 11, 2023Sold 890 shares at $20.81 of CymaBay Therapeutics (United States)⁸
• Dec 11, 2023Exercised options 890 shares at $5.00 of CymaBay Therapeutics (United States)⁸
• Dec 11, 2023Sold 63,975 shares at $19.99 of CymaBay Therapeutics (United States)⁸
• Dec 11, 2023Exercised options 63,975 shares at $5.00 of CymaBay Therapeutics (United States)⁸
• Nov 13, 2023Sold 20,855 shares at $15.89 of CymaBay Therapeutics (United States)⁹
• Nov 13, 2023Exercised options 20,855 shares at $5.00 of CymaBay Therapeutics (United States)⁹
• Nov 13, 2023Sold 44,008 shares at $15.89 of CymaBay Therapeutics (United States)⁹
• Nov 13, 2023Exercised options 44,008 shares at $5.00 of CymaBay Therapeutics (United States)⁹
• Oct 9, 2023Sold 64,861 shares at $14.20 of CymaBay Therapeutics (United States)¹⁰
• Oct 9, 2023Exercised options 64,861 shares at $5.00 of CymaBay Therapeutics (United States)¹⁰
• Jun 6, 2022Bought 51,301 shares at $1.95 of CymaBay Therapeutics (United States)¹¹